RANBAXY TO MARKET ETHYPHARM'S CARDIAC DRUG IN INDIA

Ethypharm India, subsidiary of leading French multinational Drug Delivery Company Ethypharm SA, has signed out-licensing and supply contract agreements for a Fixed Dose Combination of Fenofibrate micronized 160 mg and Atorvastatin 10 mg with Ranbaxy, based out of India, which will be launched in the Indian market. BioSpectrum (http://www.biospectrumasia.com/content/180906IND1649.asp)